Yano Junko, Palmer Glen E, Eberle Karen E, Peters Brian M, Vogl Thomas, McKenzie Andrew N, Fidel Paul L
Department of Oral and Craniofacial Biology, School of Dentistry, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Infect Immun. 2014 Feb;82(2):783-92. doi: 10.1128/IAI.00861-13. Epub 2013 Dec 9.
Vulvovaginal candidiasis (VVC), caused by Candida albicans, affects women worldwide. Animal and clinical studies suggest that the immunopathogenic inflammatory condition of VVC is initiated by S100 alarmins in response to C. albicans, which stimulate polymorphonuclear neutrophil (PMN) migration to the vagina. The purpose of this study was to extend previous in vitro data and determine the requirement for the alarmin S100A8 in the PMN response and to evaluate pattern recognition receptors (PRRs) that initiate the response. For the former, PMN migration was evaluated in vitro or in vivo in the presence or absence of S100 alarmins initiated by several approaches. For the latter, vaginal epithelial cells were evaluated for PRR expression and C. albicans-induced S100A8 and S100A9 mRNAs, followed by evaluation of the PMN response in inoculated PRR-deficient mice. Results revealed that, consistent with previously reported in vitro data, eukaryote-derived S100A8, but not prokaryote-derived recombinant S100A8, induced significant PMN chemotaxis in vivo. Conversely, a lack of biologically active S100A8 alarmin, achieved by antibody neutralization or by using S100A9(-/-) mice, had no effect on the PMN response in vivo. In PRR analyses, whereas Toll-like receptor 4 (TLR4)- and SIGNR1-deficient vaginal epithelial cells showed a dramatic reduction in C. albicans-induced S100A8/S100A9 mRNAs in vitro, inoculated mice deficient in these PRRs showed PMN migration similar to that in wild-type controls. These results suggest that S100A8 alarmin is sufficient, but not necessary, to induce PMN migration during VVC and that the vaginal PMN response to C. albicans involves PRRs in addition to SIGNR1 and TLR4, or other induction pathways.
外阴阴道念珠菌病(VVC)由白色念珠菌引起,影响着全球女性。动物和临床研究表明,VVC的免疫致病性炎症状态是由S100警报素响应白色念珠菌引发的,S100警报素刺激多形核中性粒细胞(PMN)迁移至阴道。本研究的目的是扩展先前的体外数据,确定警报素S100A8在PMN反应中的必要性,并评估引发该反应的模式识别受体(PRR)。对于前者,通过几种方法在有或没有S100警报素的情况下,在体外或体内评估PMN迁移。对于后者,评估阴道上皮细胞的PRR表达以及白色念珠菌诱导的S100A8和S100A9 mRNA,随后在接种PRR缺陷小鼠中评估PMN反应。结果显示,与先前报道的体外数据一致,真核生物来源的S100A8而非原核生物来源的重组S100A8在体内诱导显著的PMN趋化作用。相反,通过抗体中和或使用S100A9(-/-)小鼠实现的缺乏生物活性的S100A8警报素对体内PMN反应没有影响。在PRR分析中,虽然Toll样受体4(TLR4)和SIGNR1缺陷的阴道上皮细胞在体外显示白色念珠菌诱导的S100A8/S100A9 mRNA显著减少,但接种这些PRR缺陷的小鼠显示PMN迁移与野生型对照相似。这些结果表明,S100A8警报素足以但非必需在VVC期间诱导PMN迁移,并且阴道对白色念珠菌的PMN反应除了SIGNR1和TLR4外还涉及PRR或其他诱导途径。